Vascular endothelial growth factor levels in serum do not increase following HIV type 1 and HHV8 seroconversion and lack correlation with AIDS-related Kaposi’s sarcoma

AIDS Research and Human Retroviruses

Volumn 18, Issue 10, 2002, Pages 695-698

  Renwick, Neil ^a   Weverling, Gerrit Jan ^a   Brouwer, Joke ^a   Bakker, Margreet ^a   Schulz, Thomas F ^b   Goudsmit, Jaap ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES VIRUS INFECTION; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; KAPOSI SARCOMA; LYMPHOCYTE COUNT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SEROCONVERSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; ENDOTHELIAL GROWTH FACTORS; HERPESVIRUS 8, HUMAN; HIV SEROPOSITIVITY; HIV-1; HUMANS; LYMPHOKINES; MALE; SARCOMA, KAPOSI; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036063880     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202760072302     Document Type: Article

References (22)

1. Vascular-specific growth factors and blood vessel formation
2. Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions
3. Kaposi's sarcoma-associated herpesvirus and sexual transmission of cancer risk
4. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma
5. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma
6. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development
7. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma
8. Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: Implications for acquired immunodeficiency syndrome-associated vasculopathy
9. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
10. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor upregulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha
11. Angiogenesis and haematopoiesis induced by Kaposi's sarcoma-associated herpesvirus encoded interleukin-6
12. The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression
13. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
14. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells
15. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells
16. 165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma
17. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma
18. Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma
19. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3
20. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma
21. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma
22. Expression of Tie-1, Tie-2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma